LabGenomics (Korea) Performance
| 084650 Stock | KRW 2,710 30.00 1.12% |
The company secures a Beta (Market Risk) of 0.33, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, LabGenomics' returns are expected to increase less than the market. However, during the bear market, the loss of holding LabGenomics is expected to be smaller as well. At this point, LabGenomics has a negative expected return of -0.18%. Please make sure to verify LabGenomics' coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if LabGenomics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days LabGenomics Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
| Total Cashflows From Investing Activities | -26.1 B |
LabGenomics |
LabGenomics Relative Risk vs. Return Landscape
If you would invest 315,000 in LabGenomics Co on August 28, 2024 and sell it today you would lose (47,000) from holding LabGenomics Co or give up 14.92% of portfolio value over 90 days. LabGenomics Co is generating negative expected returns and assumes 4.5544% volatility on return distribution over the 90 days horizon. Simply put, 40% of stocks are less volatile than LabGenomics, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
LabGenomics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for LabGenomics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as LabGenomics Co, and traders can use it to determine the average amount a LabGenomics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0388
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 084650 |
Estimated Market Risk
| 4.55 actual daily | 40 60% of assets are more volatile |
Expected Return
| -0.18 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average LabGenomics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of LabGenomics by adding LabGenomics to a well-diversified portfolio.
LabGenomics Fundamentals Growth
LabGenomics Stock prices reflect investors' perceptions of the future prospects and financial health of LabGenomics, and LabGenomics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on LabGenomics Stock performance.
| Return On Equity | 42.82 | |||
| Return On Asset | 0.46 | |||
| Profit Margin | 0.38 % | |||
| Operating Margin | 0.48 % | |||
| Current Valuation | 356.77 B | |||
| Shares Outstanding | 9.08 M | |||
| Price To Sales | 2.02 X | |||
| Revenue | 202.41 B | |||
| EBITDA | 70.81 B | |||
| Cash And Equivalents | 70.53 B | |||
| Total Debt | 4.4 B | |||
| Cash Flow From Operations | 66.08 B | |||
| Total Asset | 204.29 B | |||
About LabGenomics Performance
By analyzing LabGenomics' fundamental ratios, stakeholders can gain valuable insights into LabGenomics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if LabGenomics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if LabGenomics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about LabGenomics performance evaluation
Checking the ongoing alerts about LabGenomics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for LabGenomics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| LabGenomics generated a negative expected return over the last 90 days | |
| LabGenomics has high historical volatility and very poor performance | |
| About 13.0% of the company shares are owned by insiders or employees |
- Analyzing LabGenomics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether LabGenomics' stock is overvalued or undervalued compared to its peers.
- Examining LabGenomics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating LabGenomics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of LabGenomics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of LabGenomics' stock. These opinions can provide insight into LabGenomics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for LabGenomics Stock analysis
When running LabGenomics' price analysis, check to measure LabGenomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LabGenomics is operating at the current time. Most of LabGenomics' value examination focuses on studying past and present price action to predict the probability of LabGenomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LabGenomics' price. Additionally, you may evaluate how the addition of LabGenomics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |